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Abstract
Pax3 has numerous integral functions in embryonic tissue morphogenesis and knowledge of its complex function in cells of
adult tissue continues to unfold. Across a variety of adult tissue lineages, the role of Pax3 is principally linked to
maintenance of the tissue’s resident stem/progenitor cell population. In adult peripheral nerves, Pax3 is reported to be
expressed in nonmyelinating Schwann cells, however, little is known about the purpose of this expression. Based on the
evidence of the role of Pax3 in other adult tissue stem and progenitor cells, it was hypothesised that the cells in adult
peripheral nerve that express Pax3 may be peripheral glioblasts. Here, methods have been developed for identification and
visualisation of Pax3 expressant cells in normal 60 day old mouse peripheral nerve that allowed morphological and
phenotypic distinctions to be made between Pax3 expressing cells and other nonmyelinating Schwann cells. The
distinctions described provide compelling support for a resident glioblast population in adult mouse peripheral nerve.
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Introduction
The paired-box homeotic gene 3 (PAX3) encodes the PAX3
transcription factor that is known to regulate transcriptional
activation or repression of a broad spectrum of downstream
genes in a variety of developmental pathways. PAX3 functions
after embryogenesis relate to regulatory roles in the ontogeny of
stem cells throughout the postnatal lifespan of the organism.
The roles of PAX3/Pax3 are well defined across a variety of
adult tissue lineages [1–12]. From these studies, it can be
concluded that the overarching purpose for continued expres-
sion of PAX3/Pax3 in adult tissues is primarily for maintenance
of a progenitor cell population. In adult progenitor cells it is
said that PAX3/Pax3 protects the ‘stemness’ of the cell through
regulation of downstream target genes involved in the mainte-
nance of an undifferentiated phenotype and in its absence, cells
acquire the characteristics of a mature cell [13].
Pax3 is known to be expressed in a characteristic, temporal
pattern in Schwann cells of the developing peripheral nervous
system [14]. Kioussi and colleagues [14] report that Pax3 RNA
is associated with nonmyelinating Schwann cells (NMSCs) of 30
day old mouse sciatic nerve; this report of continued Pax3
expression in adult cells of neural crest origin was thought
intriguing. Therefore, investigations focused on determination of
the Pax3 mRNA transcripts and double-labeling of Pax3 with
other early immature Schwann cell markers in normal 60 day
old mouse sciatic nerve and results demonstrate that cells that
express Pax3 are characterised by a peripheral glioblast
phenotype.
Results
Pax3 mRNA Transcripts are Expressed in 60 Day Old
Mouse Sciatic Nerve
There are conflicting reports about the expression of PAX3/
Pax3 in Schwann cells of adult peripheral nerve [14–16]; so, the
initial aim of the investigations was to report the Pax3 mRNA
transcripts in normal mouse sciatic nerve. To identify all possible
Mus musculus mRNA transcripts, the mouse genome sequence
available on the NCBI was interrogated for all possible splice sites.
Three mouse transcripts have been sequenced to date; Pax3c and
Pax3d are expressed in embryonic cells of the myogenic and
melanogenic lineages [17] and Pax3ˆ8, which encodes a transcrip-
tionally inactive isoform, is expressed in embryonic myogenic
precursors [18]. Barber et al. [17] have reported a Pax3f
transcript, expressed in the embryonic day 9.5 mice and although
exact sequence data is unavailable, it is thought that the transcript
is generated by splicing exon 5 directly to exon 9 using the known
splice donor and acceptor sequences.
To delineate whether the production of additional mouse
transcripts of Pax3 is possible, a comparison of human and mouse
nucleotide sequences was undertaken using the NCBI BLAST
database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to search for
mouse consensus donor and acceptor splice sequences contained
within the Pax3 locus. The amino acid sequences from 197–215 of
human PAX3a or 197–206 of PAX3b are not homologous to
those of mouse Pax3 [19,20] and there is no record of a Mus
musculus transcript Pax3a or Pax3b. The mouse Pax3 gene shows
a lack of consensus splice site elements required for production of
homologous Pax3e, Pax3g and Pax3h transcripts as those produced
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in humans; moreover, the mouse Pax3 genomic sequence diverges
from the human gene in the 39 region from which these transcripts
are produced and shows less than 70% homology to the human
sequence (Murine clone RP24-529B23 Chromosome 1).
As such, specific primers were designed to amplify the mRNA of
mouse Pax3c, Pax3d, Pax3f and Pax3ˆ8 transcripts. RT-PCR results
confirmed that 2 alternate Pax3 mRNA transcripts were expressed
in 60 day old mouse sciatic nerve (n = 6). Pax3c or Pax3d transcripts
were detectable in 4/6 individual nerves, although co-expression
of both transcripts was not observed. In 2/6 nerves analysed, Pax3
mRNA was undetectable. In all nerves tested, PCR amplification
of Pax3ˆ8 and Pax3f mRNA products were undetectable (Fig. 1).
The Morphology of 60 Day Old Mouse NMSCs of Sciatic
Nerve
In the adult peripheral nervous system, C-fibre neurons are not
myelinated and are organised into a bundle in which many nerve
fibres are ensheathed by one NMSC for conduction of peripheral
afferent signals. NMSCs have a characteristic morphology that
consists of long branching networks of cytoplasmic processes which
coalesce in a plexiform manner with adjacent nonmyelinated
bundles [21,22]. To date, the morphology of mouse NMSCs that
make up nonmyelinated bundles have been loosely characterised.
In this study, mouse NMSCs were clearly visualised by
fluorescence microscopy of teased sciatic nerve fibre specimens
(data not shown); the morphology of the cell is stated as 2–4 mm in
diameter across the cytoplasmic extensions and 4–5 mm in
diameter across the nuclear region. The length of the cell is
between 80–200 um and the nucleus is between 12–20 um in
length. The nucleus of the NMSC is centrally located (as opposed
to the peripheral location of the nucleus of a myelinating Schwann
cell) and the nonmyelinated C-fibres that traverse longitudinally
across the NMSC nucleus form it into a characteristic ‘cigar’ or
spindle shape such as has been described for rat NMSCs [23].
It is known that nonmyelinated bundles contain two classes of
C-fibres, those dependent on nerve growth factor (NGF) that
express low-affinity nerve growth factor receptor (p75Ngfr) and
those dependent on glial-derived neurotrophic factor that express
glial-derived neurotrophic factor family receptor-a1 [22]. It is also
known that p75Ngfr is expressed on the NMSC plasmalemma
adjacent to a NGF-dependent C-fibre it ensheathes [23];
therefore, p75Ngfr was chosen to label NMSCs associated with
NGF-dependent C-fibres. Here, the plexiform nature of non-
myelinated NGF-dependent C-fibres, described by Carlsen, Behse
[21] in human and Murinson et al. [22] in rat, was seen in 60 day
old mouse by the immunofluorescence labeling (Fig. 2).
Figure 1. Pax3 transcripts are expressed in normal adult mouse peripheral nerve. Gel electrophoresis of PCR amplification products of Pax3
transcripts from normal mouse sciatic nerves. All PCR products are compared to pUC DNA ladder. A) Pax3c (117 bp) was expressed in 3/6 nerves
tested while Pax3d (97 bp) was expressed in 1/6 nerves tested. Pax3 products were not amplified in 2/6 nerves tested. B) Positive controls for relative
amounts of Gapdh product amplified from the total RNA of the six nerve lysates are shown.
doi:10.1371/journal.pone.0059184.g001
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Characterisation of Cells that Express Pax3 in Normal
Adult Mouse Sciatic Nerve
RT-PCR results verified that Pax3c and Pax3d transcripts were
present in 60 day old mouse sciatic nerve (Fig. 1), thus, it remained
to confirm the presence of the proteins encoded by these
transcripts in the mouse tissue. A mouse monoclonal IgG2a
isotype-specific antibody directed at amino acids that form the
transactivation domain of the Pax3 protein [24] was employed and
when used with the isotype-specific anti-mouse IgG2a secondary
antibody, non-specific background staining of endogenous mouse
tissue IgGs and other components was minimised.
Development of the Pax3 immunofluorescent labeling method
commenced using frozen sections of mouse sciatic nerve pre- and/
or postfixed with 4% w/v paraformaldehyde (PFA) and a second-
ary indirect immunofluorescence procedure. In both tangental and
longitudinal sections, a nuclear Pax3 label was undetectable. As
indicated by the RT-PCR results, Pax3 expression levels were
expected to be relatively low, thus, a tertiary (avidin/biotin)
indirect immunofluorescence procedure was also performed on the
frozen sections. When this method was analysed, levels of non-
specific background staining were high and a nuclear Pax3 label
remained undetectable (data not shown). Next, individual 2 mm
lengths of fascicles from adult mouse sciatic nerve were pre- and/
or postfixed in PFA and teased into individual Schwann cell/axons
and indirect immunofluorescence methods were tested for Pax3
labeling. Various tissue permeabilisation protocols were also
assessed as to their effects on cellular and extracellular integrity,
nonspecific staining and intensity of immunofluorescent Pax3
label. Results showed that all methods trialed had a Pax3 label of
low intensity and, in many specimens, Schwann cell structure was
not optimal (data not shown). Positive control samples were
processed during each of the teased fibre immunolabeling
experiments using Krox24, a transcription factor reported
expressed in Schwann cells of adult peripheral nerve [25,26]. In
the positive control samples, nuclei that expressed Krox24 were
clearly distinguishable and strongly immunofluorescent (Fig. 3). It
was thus concluded that the PFA fixation method was linked to
difficulties associated with the lack of optimal Pax3 immunoflu-
orescent labeling in both the frozen and teased fibre samples
prepared.
An alternate method, consisting of a short post-fixation of dried
whole mount sciatic nerve fascicles with 4uC acetone was
subsequently found to preserve both tissue morphology and
Pax3 antigenicity, therefore, a Pax3 labeling procedure was
developed using this method of fixation and analysed using
Figure 2. The complex structure of nonmyelinated nerve bundles in normal adult mouse peripheral nerve. A micrograph of a whole
mount sciatic nerve fascicle preparation labeled with p75Ngfr (red) reveals the plexiform comingling and exchange of NGF-dependent C-fibres
between adjacent nonmyelinated bundles. Cell nuclei are visualised using Hoechst DNA dye (blue). Images were acquired using scanning laser
confocal microscopy. Optical plane = 1.5 mm. Pinhole aperture = 3.0. Scale bar represents 20 mm.
doi:10.1371/journal.pone.0059184.g002
Figure 3. Krox24 immunofluorescence in adult mouse periph-
eral nerve. A sciatic nerve fascicle post-fixed for 2 hours in PFA was
labeled with an antibody targeted at the Krox24 transcription factor. In
this micrograph, a myelinating Schwann cell nucleus (indicated by the
arrow) shows Krox24 positivity.
doi:10.1371/journal.pone.0059184.g003
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scanning laser confocal microscopy. Results showed strong Pax3
immunoreactivity in cell nuclei randomly distributed along the
length of the 60 day old sciatic nerve trunk. In the whole mount
mouse sciatic nerve fascicle specimens analysed, relatively 2% of
cell nuclei were positive for Pax3 when compared to the total
number of Hoechst stained nuclei visible along the length of the
nerve (Fig. 4D, 5B); in the nerve fascicle preparations examined
(approximately 2 mm length) there was an average of 9 cells per
specimen that showed Pax3 positivity. Notably, the Pax3
expressing cells did not have a characteristic NMSC morphology.
The shape of the nucleus was distinctly oval or round and co-
localisation with p75Ngfr revealed that Pax3+ cells lacked p75Ngfr
labeled bipolar cytoplasmic extensions (Fig. 5). In the three nerve
preparations examined for colocalisation of Pax3 and p75Ngfr,
100% of the Pax3+ cells (n = 28) co-expressed p75Ngfr in the
nucleus (Fig. 4B). It was evident that relatively 98% of Schwann
cells associated with NGF-dependent C-fibres did not express
Pax3.
It was hypothesised that cells of adult nerve that express Pax3
would co-express peripheral glioblast markers, therefore co-
localisation studies were performed using antibodies against
Pax3 and a marker of neural crest cells, transcription factor
SRY-related high-mobility group box-2 (Sox2). To date, Sox2
expression has been thought limited to embryonic glioblasts [27];
however, it is detected here for the first time in mouse sciatic nerve
of 60 day old animals. Across the three Pax3 and Sox2 double-
labeled whole mount sciatic nerve fascicles examined, 100% of
cells that had nuclear Pax3 expression also had nuclear Sox2
expression (n= 22) (Fig. 6) and again, cells that had Pax3/Sox2
positivity were approximately 2% of the total cells imaged.
Discussion
This study was primarily concerned with the expression of
a developmental transcription factor, Pax3, in adult mouse
peripheral nerve. No studies have discussed Pax3 protein
expression in normal adult mouse NMSCs and thus it was
compelling to investigate and contemplate the implications of Pax3
expression, as previously reported, knowing the roles of Pax3/Pax3
across other adult lineages such as melanocyte and skeletal muscle.
It is important to note that initial development of the methods
were based on an assumption that all of the P60 NMSC of
peripheral nerve would express Pax3/Pax3, as it had been
reported previously that the expression in P30 nerves was linked
to inhibition of key myelination genes [14]. Our findings, which
refute this, were tested using a variety of rigorously optimised
methods. Taken together, the immunofluorescent labeling and
RT-PCR results support one of the key findings of the study,
namely, that Pax3 expression is demonstrated in only 2% of adult
NMSCs. That Pax3 does not have a continuing role in the
inhibition of myelination genes within adult NMSCs after P30 is
supported by reports that cell fate specification to the myelinating
phenotype occurs between E16 and birth and is principally linked
to associated nerve fibre caliber and dose-dependent secretion of
axonal factors [28–30].
The Pax3 expression pattern seen in adult peripheral nerve is
similar to that seen in adult skeletal muscle where Pax3/7
expressing stem (satellite) cells account for up to 4% of the total
myonuclei [31]. That Pax3 transcripts were below the level of
detection in some of the nerves tested here by RT-PCR, was
confirmed by the fact that approximately 2% of cells within the
nerve trunk express Pax3 at age 60 days. These findings are in
agreement with other studies which failed to label Pax3/Pax3 in
adult peripheral nerve [15,16].
Pax3 Expressing Cells in Adult Mouse Peripheral Nerve
Co-express Stem Cell Markers
Based on the evidence of the role of Pax3 in other adult tissue
stem and progenitor cells, and taken together with evidence that
a population of cells exist in adult peripheral nerve that express
Pax3 [14], it was hypothesised that these Pax3+ cells may be
peripheral glioblasts. Therefore, aims of the investigations
continued to focused on identification, visualisation and initial
characterisation of the cells of adult mouse peripheral nerve that
express Pax3. The most significant finding is a population of cells
that co-express Pax3, Sox2 and p75Ngfr have been identified.
These proteins are commonly expressed in multipotent cells in
a variety of tissues [32–35] and while the role of Pax3 in Schwann
cells remains largely undetermined, its overarching role in other
tissues is maintenance of progenitor cells across the life span [9]. In
Schwann cells, Sox2 has been shown to increase responsiveness to
proliferative stimuli, prevent myelin gene expression and inhibit
differentiation [27,36]. SOX2 is one of the four Yamanaka factors,
or genes whose expression is artificially forced to induce non-
pluripotent adult somatic cells into pluripotent stem cells (iPSCs)
in vitro. In the progress toward clinical application of iPSCs, both
SOX2 and PAX3 have key roles in the generation, identification
and maintenance of patient-specific iPSCs in vitro [37–39]. The
demonstration of the novel subset of cells described in these
investigations, although preliminary, is thought initial, sound
evidence of the existence of peripheral glioblasts in adult mouse
peripheral nerve.
Pax3 Expressing Cells are Distinct from Other NMSCs of
Adult Peripheral Nerve
Labeling procedures allowed several distinctions to be made
between Pax3 expressing cells and other NMSCs. Firstly, it was
seen that the Pax3+ cells co-expressed p75Ngfr in the nucleus but
lacked p75Ngfr+ bipolar cytoplasmic extensions. While it is
possible that Pax3 expressant cells may associate with glial-derived
neurotrophic factor dependent C-fibres (future studies should
address this question), the p75Ngfr nuclear expression pattern
would be curious; on the other hand, the p75Ngfr/Pax3+ nuclear
expression is consistent with that of a peripheral glioblast [40] and
is similar to denervated Schwann cells in vitro which when released
from axonal contact upregulate p75Ngfr and secrete nerve growth
factor for autocrine survival [41].
The morphologic and phenotypic differences of the Pax3
expressing cells described here lend credence to the theory that
peripheral glioblasts may be retained in peripheral nerve after
birth [42,43]. Transition from the embryonic Schwann precursor
to the ‘committed’, or immature Schwann phenotype progresses at
embryonic day 12 in the mouse, at which time changes are
associated with the establishment of an autocrine survival circuit.
Where precursor Schwann undergo apoptosis in the absence of
axonal trophic support, immature Schwann cells survive via
autocrine secretion of growth factors such as neurotrophin-3,
a ligand of p75Ngfr; at this stage, the fated peripheral glioblasts
express Pax3, p75Ngfr and Sox2 and are capable of self-survival
[29,44–50]. Thus, it may be theorised that a population of these
cells are retained into adulthood and may be the origin of the
Pax3/Sox2/p75Ngfr expressant cells described here.
Finally, in the mouse after birth, a subset of Schwann cells that
associate with C-fibres differentiate toward a nonmyelinating
phenotype, re-establish dependency on paracrine signaling for
survival [51] and form the peripheral nonmyelinated nerve
bundles. Of note is the finding that 60 day old NMSCs that form
the nonmyelinated bundles associated with NGF-dependent C-
Pax3 Expressant Cells in Adult Peripheral Nerve
PLOS ONE | www.plosone.org 4 March 2013 | Volume 8 | Issue 3 | e59184
fibres did not express Pax3, which indicates that expression is
down-regulated from postnatal day 30 when Kioussi et al. [14] last
report its expression. Thus, Pax3 appears to have a temporal
postnatal role in the suppression of myelination genes in a large
subset of NMSCs much the same as it does in myelinating
Schwann cells [14].
Prospective Roles for Resident Glioblasts in Adult
Peripheral Nerve
Peripheral nerve injuries, in which the nerve trunk is severed,
result in separation of the axon from the nucleus and a subsequent
inflammatory response called Wallerian degeneration. A funda-
Figure 4. p75Ngfr and Pax3 co-localisation in normal adult mouse peripheral nerve. A) The Pax3 expressing cell (indicated by the arrow)
is oval and has nuclear expression of p75Ngfr (B). D) The merged images of Pax3 (A), p75Ngfr (B) and Hoechst DNA dye (C) immunofluorescence. E)
The Pax3+ nucleus indicated (green) was imaged on a different focal plane than A-D such that it could be more clearly evident that it does not have
p75Ngfr cytoplasmic extensions (arrow). Images were acquired using scanning laser confocal microscopy. Optical plane = 1.5 mm. Pinhole
aperture = 3.5. Scale bar represents 20 mm.
doi:10.1371/journal.pone.0059184.g004
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mental characteristic of Wallerian degeneration is the reported
plasticity of adult myelinating Schwann cells to revert from the
myelinogenic transcriptional program (or differentiated state) into
the cell cycle and back [52]. Briefly, myelinating Schwann cell
nuclei enter the DNA synthesis phase while the myelin sheath is
relatively intact [53], although re-entry into the cell cycle
represents a commitment to demyelination [54]. In the distal
stump of the transected nerve, cells discard degraded myelin into
cytoplasmic ovoids and initialise autophagocytosis of myelin
proteins and lipids [55–58] while concomitant inhibition of genes
Figure 5. Distinctions between Pax3 expressant cells and the NMSC associated with NGF-dependent C-fibres. A) The cell indicated by
the arrow has the characteristic morphology of the NMSCs associated with NGF-dependent C-fibres. Note the spindle shaped nucleus (blue) and
p75+ cytoplasmic extensions (red). B) The cell indicated by the arrow typifies the morphology of the Pax3+ cells imaged in the study. The nucleus is
oval and there are no associated p75+cytoplasmic extensions apparent.
doi:10.1371/journal.pone.0059184.g005
Figure 6. Transcription factors Pax3 and Sox2 co-localise in the nuclei of cells of adult mouse peripheral nerve. Whole mount sciatic
nerve fascicles co-immunolabeled with Pax3 (green), Sox2 (red) and Hoechst DNA dye (blue) revealed that Pax3 expressant nuclei co-express stem
cell marker Sox2 (indicated by the arrows). Images were acquired using scanning laser confocal microscopy. Optical Plane = 1.5 mm. Pinhole
aperture = 3.5. Scale bar represents 20 mm.
doi:10.1371/journal.pone.0059184.g006
Pax3 Expressant Cells in Adult Peripheral Nerve
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encoding for myelin proteins occurs [59–62]. Pax3 is upregulated
at this stage followed by induction of the characteristic immature
Schwann cell markers [14]. These immature Schwann cells
proliferate within the persisting basal lamina [63,64] which
provides a pathway that proximally regenerating axons use to
reach the original target tissue [55,65–68]. As Schwann cells begin
to produce and store myelin for remyelination of regenerating
axons, Pax3 levels temporally peak; by contrast, as myelination
nears completion, Pax3 is re-silenced [14]. While theories for the
function of Pax3 in myelinated nerve regeneration include
prevention of premature myelogenesis and/or orchestration of
Schwann progeny migration, development of efficacious methods
for identification and visualisation of Pax3 expressing cells in adult
peripheral nerve, a primary result of this work, will facilitate future
studies of the role of Pax3 in myelinated peripheral nerve
regeneration.
Here, the question arises as to why the peripheral nerve trunk
would harbour resident glioblasts when myelinating Schwann cells
have the capability to de-differentiate. Several suppositions come
to mind. Resident glioblasts would proliferate (initially) at a greater
rate than a lost myelinating cell, which must extrude and degrade
myelin debris before it undergoes proliferation and thus resident
glioblasts could be an early source of regenerative Schwann cells.
In support of this notion is a study by Griffin et al [69] in which
paranodal de-myelination was induced (the myelinated Schwann
cells were not lost) and results demonstrated that supernumary
Schwann cells had migrated through the endoneurium to overlie
areas of paranodal de-myelination. The origin of the supernumary
Schwann cells remain unknown, however, the authors suggest that
they may have arisen from adjacent nonmyelinated bundles as the
supernumary cells appeared situated outside the basal lamina of
the damaged myelinated Schwann cells.
Furthermore, there are very few studies outlining the
mechanisms of nonmyelinated nerve regeneration and it is
possible that resident glioblasts may have a role along these
lines. Support for this comes from two studies. Neurofibroma-
tosis Type 1 (NF1) is characterised by loss of the NF1 gene that
encodes neurofibromin [27,70,71] and persons affected are
predisposed to develop benign peripheral nerve sheath tumours
(or neurofibromas), myeloid leukemia, hyperpigmentation of the
skin and learning disabilities [72–74]; moreover, persons with
a loss of heterozygosity of NF1 alleles develop malignant
peripheral nerve sheath tumours [75]. Neurofibromas consist
primarily of NMSCs [75–77] where malignant transformation is
linked to NMSC hyperproliferation and detrimental effects on
adjacent cells [78]. Importantly, in neurofibroma, it has been
found that tumours have a significant population of stem cells
[79] and although the origin of the stem cells remains unknown,
Pongpudpunth et al [79] proposed that ‘‘formation of neurofi-
bromas may be linked to alterations in the self-renewal program
of peripheral nerve progenitor cells’’.
Finally, a recent study has demonstrated a population of Pax3+
immature Schwann cells in the cutaneous nerve plexus of the
dermis [80]; interestingly, these cells are associated with the
unmyelinated nerves of the hair follicle [80,81]. Based on an
understanding of the prominent structural plasticity of the
innervation of the hair follicle during hair cycle changes, it is
possible that the Pax3+ Schwann cells are resident glioblasts that
have a role in the regeneration of unmyelinated nerves during
each hair cycle. The Pax3-GFP model holds much potential for
the future study of both the Pax3+ Schwann cells described by
Djian-Zaouche et al [80] and the further characterisation of the
Pax3+ cells described here.
Conclusion
In 2008, Griffin and Thompson stated that ‘‘the possibility of
a population of Schwann cell precursors in adult nerves is largely
unexplored’’ [54]. The current investigations were intended to
build on the previous work of others who showed that Pax3,
a classic stem/progenitor cell marker, is detected in adult
peripheral nerve trunk. Importantly, our results provide compel-
ling evidence for the existence of glioblasts in adult mouse
peripheral nerve and may support the long held theory that
embryonic glioblasts are retained in adult peripheral nerve much
the same as occurs in other adult Pax3-regulated tissue lineages.
Thus, studies are ongoing to further characterise the subset of
adult peripheral glial cells described here.
Methods were also developed and described that allowed the
visualisation and further characterisation of NMSCs that associate
with NGF-dependent C-fibres of normal 60 day old mouse
peripheral nerve. To date, neurological studies of this kind have
been performed on larger animals such as frog, rat, cat and dog.
The intricate and complex morphological characteristics of mouse
NMSCs described here, along with the procedures for imaging
these cells, provides a foundation for further studies of NMSCs in
mouse and may be particularly useful for studies using transgenic
animals.
Materials and Methods
Animals
Experimental procedures were carried out in accordance with
the provisions of the National Health and Medical Research
Council Australian Code for Responsible Conduct of Research
(2007), the Australian code of practice for the care and use of
animals for scientific purposes (2004) and the Animal Welfare Act
(2002). Experimentation was approved by the Edith Cowan
University Animal Ethics Committee (project approval code 06-
A7 ZIMAN). The age of the animals was chosen to reflect the
cellular makeup of adult or mature tissue. All the investigations
described were undertaken using 60 day old male mice that were
provided by the Animal Resources Centre (Canning Vale,
Western Australia).
Isolation of RNA from Sciatic Nerve Specimens
Mice were sacrificed by CO2 narcosis at 20%/min v/v and the
sciatic nerves were rapidly excised in an aseptic field. Nerves were
dissected and ligated under a Leica Zoom 2000 dissecting
microscope, with care taken to remove connective fascia from
the epineurium. Freshly removed nerve tissue was immediately
frozen by immersion in liquid nitrogen and stored at 280uC until
further use. Total RNA was isolated from single sciatic nerves
using TriReagent (Molecular Research Center, Inc.) and homog-
enisation with a glass-col mortar and pestle. For each extraction,
RNA purity and concentration were assessed using a Bioanalyzer
(Agilent).
RT-PCR
First strand cDNA was synthesised from 2 mg of isolated RNA
using an OmniScript system (Qiagen) and an oligo(dT)18 primer
(10 mM) (Qiagen). Reverse transcription was carried out at 37uC
for 1 hour in a total volume of 20 ml. Negative controls included
reactions without Omniscript reverse transcriptase. PCR amplifi-
cations were performed using a TaqDNA Polymerase Kit (Qiagen)
and a negative control (without template DNA) was included in
every experiment. The PCR reaction was conducted with the
following oligonucleotides, designed using OligoAnalyser 3.1
(Integrated DNA Technologies) and Primer-BLAST (NCBI):
Pax3 Expressant Cells in Adult Peripheral Nerve
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Pax3c: (F) 59-ACCAGGCATGGATTTTCAAG;
(R) 59-AACGTCCAAGGCTTACTTTG.
Pax3d: (F) 59-CCTCAGGTAATGGGACTTCT;
(R) 59-AATGAAAGGCACTTTGTCCA.
Pax3ˆ8: (F) 59-CTGTGTCAGATCCCAGCA;
(R) 59-GAGATAATGAAAGGCACCTGAG.
Pax3f: (F) 59-CAGATGAAGGCTCCGATATTGAC;
(R) 59-CTGGCTTGAGATAATGAAAGGC.
Internal controls for cDNA were performed using PCR
amplification of mouse housekeeping gene Gapdh and the primers
used were as follows:
Gapdh: (F) 59-GTGAAGGTCGGTGTGAACG;
(R) 59-ATTTGATGTTAGTGGGGTCTCG.
Positive controls for primers were performed using total RNA
isolated from embryonic day 11 mice and PCR negative controls
eliminated cDNA as primer template from each PCR reaction.
PCR products were resolved on 1.5% w/v agarose gels and
visualised under UV light using a Geldoc system. PCR products
were sequenced using an ABI PRISM BigDye Terminator Cycle
Sequencing Ready Reaction Kit (PE Biosystems) and an ABI
Prism 3730 48 capillary sequencer. Sequences were aligned with
known sequences in GenBank using the multiAlign tool in Angis,
available on GenBank.
Preparation of Frozen Nerve Sections
To prepare fresh frozen sections of sciatic nerve, animals were
sacrificed by cervical disslocation. The sciatic nerves were
surgically excised, immersed in Tissue Tek O.C.T. (Sakura
Finetek Europe) and frozen in liquid nitrogen cooled N-methyl
butane (Sigma). Tissue blocks were cryosectioned at 9 mm onto
SuperFrost slides (Menzel-Gla¨ser), dried and fixed in 4% para-
formaldehyde in 0.1 M phosphate buffer (PFA) for 30 minutes.
Sections were washed in phosphate buffered saline (PBS) 3 times
for 5 minutes prior to subsequent processing or storage at 280uC.
To prepare pre-fixed frozen sections, animals were anaesthetised
with Nembutal (Abbott) and transcardially perfused through the
left ventricle; a constant flow (10 mL/min) of PBS (10 mL)
followed by ice cold PFA in 0.1 M phosphate buffer at pH 7.4
(50 mL) was established using a peristaltic pump. Sciatic nerves
were surgically excised, post-fixed in PFA for 6 hours before
immersion in 30% sucrose for 48 hours. Tissues were rinsed in
PBS, immersed in Tissue Tek O.C.T. and frozen in liquid
nitrogen cooled N-methyl butane prior to cryosectioning at 9 mm
onto SuperFrost slides (Menzel-Gla¨ser). Slides were dried prior to
processing or storage at 280uC.
Preparation of Teased Nerve Specimens
To prepare pre-fixed teased nerves, animals were anaesthetised
with 75 mg/g Nembutal (Abbott) and transcardially perfused
through the left ventricle; a constant flow (10 mL/min) of PBS
(10 mL) followed by ice cold paraformaldehyde (PFA) in 0.1 M
phosphate buffer at pH 7.4 (50 mL) was established using
a peristaltic pump. Sciatic nerves were immediately excised and
postfixed in 4% w/v PFA for 18 hours at 4uC. Nerves were rinsed
in PBS and prepared onto chilled polylysine slides (Menzel-Gla¨ser)
where fascicles were cut into 2 mm lengths and individual fibres
were teased apart along the length by 0.2 mm entomology pins.
Preparations were dried for 18 hours before immunohistochemical
processing or storage at 280uC.
Preparation of Whole Mount Nerve Fascicle Specimens
Whole mount preparations were prepared using freshly excised
nerves which were obtained from animals sacrificed using CO2
narcosis. Sciatic nerves were excised and prepared on chilled
polylysine slides where fascicles were separated and cut into 2 mm
segments and mounted by the epineurium. Slides were dried
overnight, post-fixed in acetone for 10 minutes at 220uC and
rinsed in PBS at pH 7.4, before immunohistochemical processing
or storage at 280uC.
Antibodies Used for Immunofluorescence
Primary antibodies used were mouse monoclonal IgG2a anti-
quail Pax3 (1:10; Developmental Studies Hybridoma Bank); rabbit
polyclonal anti-mouse Krox24 (1:250; Aviva Systems Biology);
rabbit polyclonal anti-mouse Sox2 (1:200; Sapphire Bioscience)
and rabbit polyclonal anti-mouse p75 nerve growth factor receptor
(1:500; Chemicon). Species specific secondary antibodies used
were AlexaFluor488-conjugated to goat anti-mouse IgG2a (1:500;
Molecular Probes) and AlexaFluor546-conjugated to goat anti-
rabbit IgG (1:500; Molecular Probes).
Procedure for Immunofluorescent Staining of Whole
Mount Nerve Fascicles
Slides were rehydrated in Tris buffered saline (TBS) and
permeabilised in 0.01% v/v Triton X100 (for 45 minutes at 25uC.
Slides were washed in TBS 3 times for 10 minutes each prior to
incubation in 10% v/v normal goat serum for 6 hours at 25uC.
Primary antibodies were individually or simultaneously incubated
with 0.2% v/v TritonX100 for 18 hours at 4uC. Specimens were
washed in 0.05% v/v TBS/Tween20, 6 times for 30 minutes each,
using gentle agitation. Secondary antibody incubation was done
thereafter at 25uC for 20 minutes. Specimens were washed in
TBS/Tween20, 6 times for 30 minutes using gentle agitation
where the last wash contained Hoechst DNA dye 33342 (1 ng/ml).
Coverslips were mounted with FluorSave medium (Calbiochem).
Negative controls were processed at the same time but were not
incubated with primary or secondary antibody.
Microscopy
Fluorescently labeled tissues were viewed with an Olympus
BX51 microscope connected to an Olympus DP71 digital camera
and digital images were collected in the Olympus analySIS FIVE
program and transferred to the IrfanView (4.27) program for
montage construction. The contrast and brightness of these images
were unaltered. Whole mount specimens were imaged with
a BioRad MRC 1000/1024 UV laser scanning confocal micro-
scope on a Nikon Diaphot 300 with either a 40X objective (with
zoom) or 60X immersion objective (without zoom) using a 351-
and 488-nanometer argon laser and a 543-nanometer helium/
neon laser. Gain and black level adjustments were performed to
improve analogue to digital signal conversion and background
noise was eliminated using a KALMAN filter. Z-stacks were
collected using various step-sizes and KALMAN averaging was
performed manually for each step. Digital images were collected
and compiled in greyscale and subsequently pseudocoloured with
hues approximate to the fluorescence emission spectra of the
respective fluorophores using the Confocal AssistantTM (4.02)
program. Images were transferred to Adobe Photoshop (7.0) and
IrfanView (4.27) programs for montage construction. The images
were unaltered.
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